Music During ESWL for Half Treatment

Music Listening to Decrease Pain and Discomfort During Extracorporeal Shock Wave Lithotripsy (SWL): a Prospective Randomized Trial.

The aim of this study is to evaluate if music listening relieves pain and discomfort during Extracorporeal Shock-Waves Lithotripsy (ESWL).

Study Overview

Detailed Description

Patients undergoing ESWL and interested in music listening are randomly divided in two groups: patients in group A listen to music during the first part of the treatment (first 1800 SW), patients in group B during the second part.

At the end of the treatment patients are asked to fill in a questionnaire. They are asked if they were pleased to have had the opportunity to listen to music during ESWL, if they would like to listen to music again in case of further treatments, if they consider music helpful in relieving pain and discomfort during ESWL. Patients are also asked to mark their level of pain during each part of the treatment on a visual analogue scale (VAS) for pain.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turin, Italy, 10126
        • AOU Città della Salute e della Scienza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients undergoing ESWL from February 2011 to October 2012 and interested in music listening

Exclusion Criteria:

  • Contraindication to ESWL
  • No interest in music listening
  • < 18 years and > 80 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Music during the first part of ESWL
Patients listen to music during the first part of ESWL treatment (first 1800 SW).
Music listening during first part of ESWL
ACTIVE_COMPARATOR: Music during the second part of ESWL
Patients listen to music during the second part of ESWL treatment.
Music listening during second part of ESWL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of patients who appreciated music listening during SWL without anesthesia
Time Frame: 10 mins after SWL treatment completed
patients were asked if they appreciated music listening during swl
10 mins after SWL treatment completed

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in VAS score
Time Frame: 10 mins after SWL treatment completed
Visual analogue scale (VAS) - 0 to 10, higher values, worse pain
10 mins after SWL treatment completed
change in analgesic request
Time Frame: 10 mins after SWL treatment completed
change in analgesic request
10 mins after SWL treatment completed
change in requested interruptions
Time Frame: 10 mins after SWL treatment completed
change in requested interruptions
10 mins after SWL treatment completed
percentage of patients who considered music useful to relieve pain
Time Frame: 10 mins after SWL treatment completed
patients were asked if they considered music useful to relieve pain during swl
10 mins after SWL treatment completed
change in SW voltage (kV)
Time Frame: 10 mins after SWL treatment completed
change in SW voltage (kV)
10 mins after SWL treatment completed
change on VAS scores separately measured in each part of the treatment
Time Frame: 10 mins after SWL treatment completed
Visual analogue scale (VAS) - 0 to 10, higher values, worse pain
10 mins after SWL treatment completed

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Andrea MD Bosio, MD, AOU città dellaSalute e della Scienza, Torino
  • Principal Investigator: Andrea MD Bosio, MD, AOU città dellaSalute e della Scienza, Torino
  • Study Director: Andrea MD Bosio, MD, AOU città dellaSalute e della Scienza, Torino

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 2, 2017

Primary Completion (ACTUAL)

October 25, 2017

Study Completion (ACTUAL)

October 25, 2017

Study Registration Dates

First Submitted

December 4, 2015

First Submitted That Met QC Criteria

April 6, 2020

First Posted (ACTUAL)

April 8, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 8, 2020

Last Update Submitted That Met QC Criteria

April 6, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urolithiasis

Clinical Trials on Music during the first part of ESWL

3
Subscribe